Global Map > Startups > Western Europe > France > Bordeaux > LNC Therapeutics
LNC Therapeutics icon
Between 2010 and 2017, LNC focused exclusively on developing medical nutrition products. This work led to the development of Stablor®. The demonstration of its clinical efficacy in visceral fat loss and cardiometabolic risk factors in obese patients with metabolic syndrome. The trial also highlighted Stablor®’s role in modulating the gut microbiome, and more specifically its effect on a family of bacteria known for its anti-obesity potential, thus opening up an array of new opportunities for the company. In 2018, based on this data, a new management team led by Georges Rawadi sparked a new strategic plan aiming to harness the potential of LNC science and focused on innovative gut microbiome-based drug discovery.
Loading startups...
Need more insights about local startups?
See more with PRO